Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group - Author's reply
Publication date
2024
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by
Abstract
Keywords
Health Policy, SDG 3 - Good Health and Well-being
Citation
Hogervorst, M A, Vreman, R, Heikkinen, I & Oortwijn, W 2024, 'Response to uncertainty management in regulatory and health technology assessment decision-making on drugs : Guidance of the HTAi-DIA Working Group - Author's reply', International Journal of Technology Assessment in Health Care, vol. 40, no. 1, e1, pp. 1-2. https://doi.org/10.1017/S0266462323002817